Did You Know...
...that after Parker Brothers executives turned down the game of Monopoly because it had "52 fundamental errors" (including taking too long to play), a copy of the game wound up in the home of the company president who stayed up until 1 a.m. to finish playing it? He was so impressed by the game that the next day he wrote to inventor Charles Darrow and offered to buy it!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7358342 | Preparation derived from shark cartilage for treatment of diseased related to excessive PHF or excessive intracellular calcium A preparation derived from shark cartilage for the treatment of diseases related to excessive PHF or Excessive intracellular calcium. ... | 04/15/2008 |
| 7357938 | Sulfacetamide formulations for treatment of rosacea A method for treating rosacea in a patient comprising administering to a patient suffering from rosacea a first topical composition comprising at least one sulfacetamide or a derivative thereof and at least one sunscreen, wherein the administration of said first com... | 04/15/2008 |
| 7341746 | Chinese herbs extract This application relates to a material which is suitable for the treatment of atopic disease, non-atopic eczema or psoriasis. The material can be extracted from a freeze-dried decoction of a mixture comprising the following Chinese herbs: Radix Ledebouriella, Fru... | 03/11/2008 |
| 7323171 | Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction Methods of using inhibitors of the CD2/LFA-3 interaction in treating skin conditions characterized by increased T cell activation and abnormal antigen presentation in the dermis and epidermis in mammals, including humans. Such conditions include psoriasis, UV damage... | 01/29/2008 |
| 7300925 | 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds Biologically active 19-nor vitamin D analogs substituted at C-2 in the A-ring with an ethylidene or an ethyl group. These compounds have preferential activity on mobilizing calcium from bone and either high or normal intestinal calcium transport activity which allow... | 11/27/2007 |
| 7220438 | Pharmacological activities of extracts This invention concerns to a topical pharmaceutical composition comprising an water soluble Curcuma extract, and suitable excipients for said topical administration; the process for obtaining said pharmaceutical compositions; the use of different Curcuma | 05/22/2007 |
| 7201925 | Treatment of ungual and subungual diseases The treatment of ungual and subungual diseases is disclosed. ... | 04/10/2007 |
| 7195781 | Method for treatment of skin disorders This invention relates to a method for the natural topical treatment of portions of skin of a person afflicted with a skin disorder such as dry skin, eczema, itchy skin, red skin, itchy eczema, inflamed skin, and/or cracked skin for the removal of itch and the resto... | 03/27/2007 |
| 7132412 | Treatment of skin diseases using a pharmaceutical preparation in colloidal form A new use of a suitable colloidal mixture of hyaluronic acids, of different molecular weights mixed together in a proper ratio in the treatment of the cutaneous diseases is described. ... | 11/07/2006 |
| 7109187 | Estrogenic compounds as anti-mitotic agents The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosa... | 09/19/2006 |
| 7090871 | Composition containing pyrrolizidine-alkaloid-free petasites Petasite preparations without hepatotoxic, carcinogenic, cytostatic and/or mutagenic effect with a rapid and/or improved action are provided. The petasite extract is recovered from a plant and/or plant parts of the genus Petasites, the petasite extract being free of... | 08/15/2006 |
| 7074777 | Vitamin D derivatives The object of the present invention is to provide a vitamin D derivative exhibiting excellent physiological activity as medicines, in particular as therapeutic agents for skin disease including psoriasis, and having decreased hypercalcemic activity. The prese... | 07/11/2006 |
| RE39096 | Treatment of skin disorders An effective treatment for skin disorders characterized by abnormal skin cell behavior, including a pharmaceutically effective amount of Halofuginone. Skin disorders which can be treated include keloids, hypertrophic scars, psoriasis, acne, seborrhea and alopecia. H... | 05/16/2006 |
| 7022332 | Sulfacetamide formulations for treatment of rosacea The present invention provides improved sulfacetamide and sulfur formulations including sunscreens for the treatment of rosacea. ... | 04/04/2006 |
| 7015209 | Hair-growing agent A hair-growing agent comprising, as active ingredients, one or more members selected from the group consisting of lysophosphatidic acids, and phosphatidic acids wherein the fatty acid residue moiety consists only of straight-chain fatty acid residues having an even ... | 03/21/2006 |
| 6979468 | Oral composition and method for the treatment of inflammatory cutaneous disorders A method and composition for the treatment of acne vulgaris, acne rosacea, and other inflammatory skin conditions comprises the oral administration of a composition comprising a dose of nicotinamide delivered at levels substantially in excess of normal dietary level... | 12/27/2005 |
| 6958359 | Vanadium compounds as anti-angiogenic agents Vanadium compounds for inhibiting angiogenesis useful for treating or preventing diabetic retinopathy, hemangiomas, cancers with abnormal blood vessel supply, restenosis following vascular injury, and the like. ... | 10/25/2005 |
| 6958153 | Skin penetration enhancing components The present invention relates to a topical formulation for the treatment of a dermatological condition which comprises a macrocyclic lactone antibiotic, immunosuppresive macrolide or a biologically active analogue, derivative or pro-drug thereof; characterized in th... | 10/25/2005 |
| 6932966 | Topically applied reconstituted ocean water mixture and method of producing and using the mixture A skin treatment mixture for treating pierced skin such as that resulting from a body piercing procedure includes sea salt, lysozyme and reconstituted ocean water. The reconstituted ocean water preferably is the product of reverse osmosis of water. The skin treatmen... | 08/23/2005 |
| 6921777 | Heteroethynylenic compounds and pharmaceutical and cosmetic compositions containing them The invention relates to novel heteroethynylenic compounds having the general formula (I): as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (derma... | 07/26/2005 |
| 6897206 | Combinations for the treatment of inflammatory disorders The invention features a method for treating a patient having an inflammatory disorder, by administering to the patient (i) a tricyclic antidepressant (e.g., amoxapine); and (ii) a corticosteroid (e.g., prednisolone) simultaneously or within 14 days of each other in... | 05/24/2005 |
| 6878388 | Vanadium compounds for treating proliferative cell disorders Vanadium compounds useful to prevent and/or inhibit adhesion, migration, and invasion of proliferative cells into surrounding tissue. ... | 04/12/2005 |
| 6875754 | Use of water-soluble β-(1,3) glucans as agents for producing therapeutic skin treatment agents The invention relates to the use of water soluble β-(1,3) glucans, which are essentially free from (1,6) links as active ingredients agents for producing therapeutic skin treatment agents. Said products strengthen the skin's immune system, counteract the formation ... | 04/05/2005 |
| 6867238 | Compositions for the treatment and prevention of cancer Compositions are provided for the topical treatment of cancer consisting of lotions, creams, sprays, suppositories or slow-release transdermal patches containing lipid-soluble, skin-penetrating organic selenium compounds in combination with inert carriers in therape... | 03/15/2005 |
| 6864251 | Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines Compounds according to formula I: wherein R1, R2, R3, R4, R5 and n are as defined herein, are administered for the treatment of inflammatory disorders mediated by ... | 03/08/2005 |
| 6863907 | Antiallergic composition and antipruritic composition An allergy preventive or itching preventive food containing persimmon leaves or a persimmon leaf extract, a persimmon leaf extract-containing cosmetic composition having the action of improving allergic rough skin conditions or alleviating itching, an allergy or itc... | 03/08/2005 |
| 6841177 | Pharmacological activities of curcuma longa extracts New pharmacological activities of Curcuma Longa extracts as antiproliferative and photosensitivisation agents and their use in proliferative diseases such as psoriasis, as reducers of plasmatic fibrinogen and the Apolipoprotein B/Apolipoprotein A-I quotient, ... | 01/11/2005 |
| 6800609 | Isolated peptide of the horny layer and user thereof The invention concerns an isolated polypeptide, of the family of calcium-fixing proteins, a mixture of polypeptides derived from proteolysis of the isolated polypeptide, compositions containing them, the uses of said polypeptide and a cosmetic treatment method for d... | 10/05/2004 |
| 6770635 | Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions Adverse inflammatory reactions can be treated by administrating to an organism a composition having diglucosylamine as the active ingredient. The preferred compound is di-Beta-D-glucopyranosylamine. A simple method for making diglucosylamine in high purity is obtain... | 08/03/2004 |
| 6764681 | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction Methods of using inhibitors of the CD2/LFA-3 interaction in treating skin conditions characterized by increased T cell activation and abnormal antigen presentation in the dermis and epidermis in mammals, including humans. Such conditions include psoriasis, UV damage... | 07/20/2004 |
| 6756060 | Anti-inflammatory and antimicrobial uses for bioactive glass compositions Compositions and methods for treating wounds to significantly reduce the healing time, reduce the incidence of scar formation, improve the success of skin grafts, reduce the inflammatory response and providing anti-bacterial treatments to a patient in need thereof, ... | 06/29/2004 |
| 6737442 | Food compositions for reducing insulin resistance The present invention relates to molecules derived from guggulipid extract which are capable of reducing insulin resistance in humans. The invention further relates food compositions and medicaments comprising such molecules which can be used to treat and/or prevent... | 05/18/2004 |
| 6710083 | Method of treating palmar and plantar fibromatosis A method of treating palmar and plantar fibromatosis is disclosed. The method includes administering to a patient of a therapeutically effective amount of a composition comprising 13-cis-retinoic acid. Preferably, the treatment method includes administering to a pat... | 03/23/2004 |
| 6703026 | Cosmetic composition containing a polyorganosiloxane and an acrylic terpolymer, and use of this composition for treating keratinous material The present application relates to cosmetic compositions containing, in a cosmetically acceptable aqueous medium, at least one polyorganosiloxane and an acrylic terpolymer, as well as to the use of these compositions for treating keratinous material, in p... | 03/09/2004 |
| 6703049 | Angiogenesis inhibitor The present invention relates to a novel angiogenesis inhibitor, more particularly, arsenolite (solid As4 O6) and composition containing the same. The arsenolite of the present invention inhibits endothelial cell proliferation and tu... | 03/09/2004 |
| 6692775 | Bactericidal gel and method for treating burns and dermal lesions A gel formulation is combined with a bactericidal concentrate which is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a sp... | 02/17/2004 |
| 6692773 | Treatment of hyperproliferative skin disorders and diseases The invention relates to the use of one or more noble metals selected from silver, gold, platinum, and palladium but most preferably silver, in a nanocrystalline form, for the treatment of a hyperproliferative skin disorder or disease such as psoriasis. A... | 02/17/2004 |
| 6686388 | Regulators of the hedgehog pathway, compositions and uses related thereto The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting a cell with a compound, such as a polypept... | 02/03/2004 |
| 6676975 | Chinese herbal composition for treating eczema and psoriasis This application relates to a material which is suitable for the treatment of atopic disease, non-atopic eczema or psoriasis. The material can be extracted from a freeze-dried decoction of a mixture comprising the following Chinese herbs: Radix Ledebourie... | 01/13/2004 |
| 6663874 | Composition to alleviate pain and topical method of applying same A composition for use by animals, including humans, to alleviate pain and/or inflammation around a painful joint, joint replacement surgery site, muscle, tendon, and/or ligament. A method to ameliorate pain and/or inflammation in or around a joint, muscle... | 12/16/2003 |
